Literature DB >> 27236483

Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.

Karl B Scheidweiler1, Matthew N Newmeyer2, Allan J Barnes3, Marilyn A Huestis3.   

Abstract

Identifying recent cannabis intake is confounded by prolonged cannabinoid excretion in chronic frequent cannabis users. We previously observed detection times ≤2.1h for cannabidiol (CBD) and cannabinol (CBN) and Δ(9)-tetrahydrocannabinol (THC)-glucuronide in whole blood after smoking, suggesting their applicability for identifying recent intake. However, whole blood collection may not occur for up to 4h during driving under the influence of drugs investigations, making a recent-use marker with a 6-8h detection window helpful for improving whole blood cannabinoid interpretation. Other minor cannabinoids cannabigerol (CBG), Δ9-tetrahydrocannabivarin (THCV), and its metabolite 11-nor-9-carboxy-THCV (THCVCOOH) might also be useful. We developed and validated a sensitive and specific liquid chromatography-tandem mass spectrometry method for quantification of THC, its phase I and glucuronide phase II metabolites, and 5 five minor cannabinoids. Cannabinoids were extracted from 200μL whole blood via disposable pipette extraction, separated on a C18 column, and detected via electrospray ionization in negative mode with scheduled multiple reaction mass spectrometric monitoring. Linear ranges were 0.5-100μg/L for THC and 11-nor-9-carboxy-THC (THCCOOH); 0.5-50μg/L for 11-hydroxy-THC (11-OH-THC), CBD, CBN, and THC-glucuronide; 1-50μg/L for CBG, THCV, and THCVCOOH; and 5-500μg/L for THCCOOH-glucuronide. Inter-day accuracy and precision at low, mid and high quality control (QC) concentrations were 95.1-113% and 2.4-8.5%, respectively (n=25). Extraction recoveries and matrix effects at low and high QC concentrations were 54.0-84.4% and -25.8-30.6%, respectively. By simultaneously monitoring multiple cannabinoids and metabolites, identification of recent cannabis administration or discrimination between licit medicinal and illicit recreational cannabis use can be improved. Published by Elsevier B.V.

Entities:  

Keywords:  Cannabinoids; Disposable pipette extraction; Recent use markers; Whole blood

Mesh:

Substances:

Year:  2016        PMID: 27236483      PMCID: PMC4955402          DOI: 10.1016/j.chroma.2016.05.024

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  29 in total

1.  The detection of Delta9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol (THCA) in whole blood using two-dimensional gas chromatography and EI-mass spectrometry.

Authors:  Rodger D Scurlock; Greg B Ohlson; David K Worthen
Journal:  J Anal Toxicol       Date:  2006-05       Impact factor: 3.367

2.  LC-MS/MS analysis of Δ9-tetrahydrocannabinolic acid A in serum after protein precipitation using an in-house synthesized deuterated internal standard.

Authors:  Ariane Wohlfarth; Nadine Roth; Volker Auwärter
Journal:  J Mass Spectrom       Date:  2012-06       Impact factor: 1.982

3.  Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study.

Authors:  M A ElSohly; H deWit; S R Wachtel; S Feng; T P Murphy
Journal:  J Anal Toxicol       Date:  2001-10       Impact factor: 3.367

4.  Detection of cannabigerol and its presumptive metabolite in human urine after Cannabis consumption.

Authors:  E Hidvégi; G P Somogyi
Journal:  Pharmazie       Date:  2010-06       Impact factor: 1.267

5.  A semi-automated solid-phase extraction liquid chromatography/tandem mass spectrometry method for the analysis of tetrahydrocannabinol and metabolites in whole blood.

Authors:  Eshwar Jagerdeo; Jason E Schaff; Madeline A Montgomery; Marc A LeBeau
Journal:  Rapid Commun Mass Spectrom       Date:  2009-09       Impact factor: 2.419

6.  Fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry for forensic analysis of cannabinoids in whole blood.

Authors:  Aurélien Thomas; Christèle Widmer; Gérard Hopfgartner; Christian Staub
Journal:  J Pharm Biomed Anal       Date:  2007-08-23       Impact factor: 3.935

7.  Validated method for the simultaneous determination of Delta9-THC and Delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization.

Authors:  Helena Teixeira; Alain Verstraete; Paula Proença; Francisco Corte-Real; Paula Monsanto; Duarte Nuno Vieira
Journal:  Forensic Sci Int       Date:  2007-07-05       Impact factor: 2.395

8.  Tetrahydrocannabinol and two of its metabolites in whole blood using liquid chromatography-tandem mass spectrometry.

Authors:  Cynthia Coulter; Elizabeth Miller; Katherine Crompton; Christine Moore
Journal:  J Anal Toxicol       Date:  2008-10       Impact factor: 3.367

9.  The analysis of delta9-tetrahydrocannabinol and metabolite in whole blood and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in urine using disposable pipette extraction with confirmation and quantification by gas chromatography-mass spectrometry.

Authors:  Jennifer L Schroeder; Laureen J Marinetti; Roy K Smith; William E Brewer; Brandi L Clelland; Stephen L Morgan
Journal:  J Anal Toxicol       Date:  2008-10       Impact factor: 3.367

10.  Determination of delta9-THC in whole blood using gas chromatography-mass spectrometry.

Authors:  Mark Hok Chi Chu; Olaf H Drummer
Journal:  J Anal Toxicol       Date:  2002 Nov-Dec       Impact factor: 3.367

View more
  8 in total

1.  Recent Self-Reported Cannabis Use Is Associated With the Biometrics of Delta-9-Tetrahydrocannabinol.

Authors:  Matthew J Smith; Eva C Alden; Amy A Herrold; Andrea Roberts; Dan Stern; Joseph Jones; Allan Barnes; Kailyn P O'Connor; Marilyn A Huestis; Hans C Breiter
Journal:  J Stud Alcohol Drugs       Date:  2018-05       Impact factor: 2.582

2.  Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.

Authors:  Randi Melissa Schuster; Kevin Potter; Ryan Vandrey; Maya Hareli; Jodi Gilman; David Schoenfeld; A Eden Evins
Journal:  J Psychopharmacol       Date:  2019-09-19       Impact factor: 4.153

3.  The acute effect of cannabis on plasma, liver and brain ammonia dynamics, a translational study.

Authors:  Osama A Abulseoud; Maria Laura Zuccoli; Lifeng Zhang; Allan Barnes; Marilyn A Huestis; Da-Ting Lin
Journal:  Eur Neuropsychopharmacol       Date:  2017-04-26       Impact factor: 4.600

4.  An Atmospheric Pressure Chemical Ionization MS/MS Assay Using Online Extraction for the Analysis of 11 Cannabinoids and Metabolites in Human Plasma and Urine.

Authors:  Jelena Klawitter; Cristina Sempio; Sophie Mörlein; Erik De Bloois; Jacek Klepacki; Thomas Henthorn; Maureen A Leehey; Edward J Hoffenberg; Kelly Knupp; George S Wang; Christian Hopfer; Greg Kinney; Russell Bowler; Nicholas Foreman; Jeffrey Galinkin; Uwe Christians; Jost Klawitter
Journal:  Ther Drug Monit       Date:  2017-10       Impact factor: 3.681

5.  Development of a Novel Nano-emulsion Formulation to Improve Intestinal Absorption of Cannabidiol.

Authors:  Yukako Nakano; Masataka Tajima; Erika Sugiyama; Vilasinee Hirunpanich Sato; Hitoshi Sato
Journal:  Med Cannabis Cannabinoids       Date:  2019-04-04

6.  Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study.

Authors:  Mehdi Farokhnia; Gray R McDiarmid; Matthew N Newmeyer; Vikas Munjal; Osama A Abulseoud; Marilyn A Huestis; Lorenzo Leggio
Journal:  Transl Psychiatry       Date:  2020-02-19       Impact factor: 6.222

7.  Miniaturized Salting-Out Assisted Liquid-Liquid Extraction Combined with Disposable Pipette Extraction for Fast Sample Preparation of Neonicotinoid Pesticides in Bee Pollen.

Authors:  Xijuan Tu; Wenbin Chen
Journal:  Molecules       Date:  2020-12-03       Impact factor: 4.411

8.  Study of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extraction FROM dried oral fluid spots (DOFS) and LC-MS/MS detection.

Authors:  Roberta Gorziza; Joseph Cox; Renata Pereira Limberger; Luis E Arroyo-Mora
Journal:  J Cannabis Res       Date:  2021-07-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.